Mind Medicine Inc Warrants(07/01/2024) Stock (OTC: MMDCF)

Latest news for Mind Medicine Inc Warrants(07/01/2024) (OTC:MMDCF) Stock

Cannabis

Penny Stocks

Psychedelics

Small Cap

Markets

BWVI

CMPS

ENVB

MMDCF

OPTHF

PSIL

TRYPF

WSNAF

The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey.

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry

Biotech

Government

News

Regulations

Psychology

General

ATAI

FTRP

What Happened: According to the Multidisciplinary Association of Psychedelic Studies (MAPS), a non-profit organization, the FDA is close to greenlighting MDMA as a treatment for PTSD. MAPS reported positive results from a phase-3 trial testing the efficacy of MDMA-assisted therapy.

These 3 Psychedelic Stocks Will Benefit When The FDA Green-Lights MDMA (Molly, Ecstasy)

CYBN

PSYC

Media company Global Trac Solutions, Inc. (OTCP:PSYC) and authorities behind psychedelic news and information platform Psychedelic Spotlight, announced that Psychedelic Spotlight will host its first “CEO Roundtable” on Feb. 15.

Cybin, MindMed, And Field Trip Health Headline PSYC&#39;s First CEO Round Table Event

Mind Medicine Inc Warrants(07/01/2024)

General Dynamics Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) will release its financial results for the second quarter, before the opening bell on <a href="https://www.benzinga.com/quote/GD/earnings">Wednesday, July 24</a>.
Analysts expect the Reston, Virginia-based company to report quarterly earnings at $3.27 per share, up from $2.7 per share in the year-ago period. General Dynamics is expected to post revenue of $11.44 billion, compared to $10.15 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
The company's business unit, Bath Iron Works, last month, clinched a contract to provide planning yard services for its DDG 51 guided-missile destroyer ships.
General Dynamics shares gained 1.1% to close at $294.46 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/GD/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Morgan Stanley analyst Kristine Liwag maintained an Equal-Weight rating and raised the price target from $271 to $293 on July 15. This analyst has an accuracy rate of 68%.</li>
<li>Baird analyst Peter Arment maintained an Outperform rating with a price target of $345 on July 2. This analyst has an accuracy rate of 84%.</li>
<li>Argus Research analyst John Eade maintained a Buy rating and boosted the price target from $290 to $310 on April 29. This analyst has an accuracy rate of 75%.</li>
<li>Jefferies analyst Sheila Kahyaoglu upgraded the stock from Hold to Buy and increased the price target from $305 to $335 on April 29. This analyst has an accuracy rate of 70%.</li>
<li>Citigroup analyst Jason Gursky maintained a Buy rating and boosted the price target from $300 to $320 on April 25. This analyst has an accuracy rate of 75%.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39906781/top-4-real-estate-stocks-which-could-rescue-your-portfolio-in-q3">Top 4 Real Estate Stocks Which Could Rescue Your Portfolio In Q3</a></li>
</ul>

Earnings

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

General Dynamics Likely To Report Higher Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

This new license supplements Hamamatsu&#39;s existing license to Adeia&#39;s DBI&reg;&nbsp;wafer-to-wafer hybrid bonding and ZiBond&reg;&nbsp;wafer-to-wafer direct bonding technologies and follows from a prior development license between the parties that included a DBI Ultra&reg;&nbsp;die-to-wafer hybrid bonding technology transfer.

ADEA

Reported Earlier, Adeia And Hamamatsu Photonics Enters Long-Term Hybrid Bonding License Agreement

The shares are expected to begin trading on the Nasdaq Global Select Market on July 24, 2024 under the symbol &quot;OS.&quot; The offering is expected to close on July 25, 2024, subject to customary closing conditions.

IPOs

Reported Earlier, OneStream Prices Initial Public Offering Of 24.5M Common Shares At $20/Share

AZTR

Reported Earlier, Azitra Prices $10M Public Offering Of 6,665,000 Common Shares And Class A Warrants At $1.50

Offerings

CSTM

Constellium Announced The Commencement Of A Proposed Private Offering Of About €300M Of Euro Denominated Senior Unsecured Notes Due 2032 And $350M Of U.S. Dollar Denominated Senior Unsecured Notes Due 2032

Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>), today unveiled its UltraFORCE&reg; 380-HDc imaging system at the Farnborough International Air Show. The new long-range airborne surveillance solution is not subject to International Traffic in Arms Regulations (ITAR), easing shipment and freedom of movement to customers outside the United States.

New Teledyne FLIR Imaging System Enhances Global Surveillance with Easier Exportation

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) to report quarterly earnings at 57 cents per share on revenue of $29.92 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. AT&amp;T shares fell 0.2% to $18.18 in after-hours trading.</li>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) <a href="https://www.benzinga.com/news/earnings/24/07/39918390/tesla-q2-earnings-highlights-revenue-beat-eps-miss-robotaxi-update-2024-growth-rate-to-be-notably-l">reported weaker-than-expected earnings</a> for its second quarter, while sales topped estimates. The company reported second-quarter deliveries of 443,956 vehicles and production of 410,831 vehicles, down 5% and 14% year-over-year, respectively. Tesla shares fell 7.8% to $227.25 in the after-hours trading session.</li>
<li>Analysts are expecting International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) to post quarterly earnings at $2.19 per share on revenue of $15.62 billion. The company will release earnings after the markets close. IBM shares fell 0.4% to $183.33 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) <a href="https://www.benzinga.com/news/earnings/24/07/39917921/alphabet-q2-earnings-revenue-beat-eps-beat-innovation-at-every-layer-of-the-ai-stack-and-more">reported upbeat earnings</a> and sales results for its second quarter on Tuesday. The company also announced a cash dividend of 20 cents per share to be paid on Sept.16 to shareholders of record as of Sept. 9. Alphabet shares slipped 2.2% to $177.83 in the after-hours trading session.</li>
<li>Analysts expect GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) to post quarterly earnings at 73 cents per share on revenue of $8.26 billion before the opening bell. GE Vernova shares rose 0.3% to $171.00 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39906781/top-4-real-estate-stocks-which-could-rescue-your-portfolio-in-q3">Top 4 Real Estate Stocks Which Could Rescue Your Portfolio In Q3</a></li>
</ul>
Photo via Shutterstock

GOOG

GOOGL

TSLA

Tesla, AT&T And 3 Stocks To Watch Heading Into Wednesday

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk said on Tuesday that most of the engineering of its <a href="https://www.benzinga.com/news/24/02/37356873/elon-musk-says-upcoming-tesla-roadster-to-debut-with-spacex-tech-for-speed-boost-there-will-never-be">upcoming second-generation Roadster</a> is completed and the company intends to start production in 2025.
What Happened: While most of the engineering is complete, there are some more updates the company intends to make on the vehicle, Musk added.
&#8220;It will be something special. Like the whole thing might be,&#8221; the CEO said about the vehicle during the company&#8217;s second-quarter earnings call. 
The new Roadster is the successor to Tesla&#8217;s first EV &#8211; the <a href="https://www.benzinga.com/news/23/07/33147963/from-mistakes-to-milestones-how-tesla-revived-the-roadster-and-why-its-a-big-deal-for-musk">limited-production first-generation Roadster</a> &#8211; produced between 2008 and 2012.
In February, Musk said that the upcoming Tesla Roadster can accelerate from 0 to 60 mph in less than 1 second, lower than the company's initial estimate of 1.9 seconds. Tesla's Model S Plaid, meanwhile, can achieve the same speed in 2.1 seconds.
"It would also obviously be ridiculous for the Roadster to achieve simply the same 0-60mph time as Model S, even though it is a 2-door fully performance-oriented vehicle," Musk later explained on X, formerly Twitter.
Why It Matters: <a href="https://www.benzinga.com/news/24/05/38817313/tesla-ceo-elon-musk-says-making-new-roadster-only-as-fast-as-model-s-plaid-would-be-ridiculous">The new Roadster</a>, Musk said earlier this year, is expected to be unveiled by the end of 2024 after the completion of production design with deliveries slated to start in 2025. The vehicle relies on a collaboration between Musk's two companies- Tesla and rocket manufacturer SpaceX- to provide incredible performance, he added. 
The new generation Roadster prototype was showcased at the end of the event dedicated to unveiling the Tesla Semi on November 16, 2017. The vehicle, Tesla then said, would be available starting in 2020 priced around $200,000.
However, the production timeline for the vehicle has been pushed several times since.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39903020/gms-cruise-abandons-pedal-less-origin-autonomous-vehicle-pivots-to-next-generation-chevrolet-bolt-in">GM&#8217;s Cruise Abandons Pedal-less Origin Autonomous Vehicle, Pivots To Next-Generation Chevrolet Bolt Instead</a></li>
</ul>
Photo courtesy: Shutterstock

SPACE

Tech

New Tesla Roadster Will Be 'Something Special,' Says CEO Elon Musk: Production To Commence In 2025

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk has endorsed Cathie Wood-led ARK Invest&#8216;s $5 trillion valuation forecast for the electric vehicle manufacturer, suggesting it may be conservative. Musk made these remarks during Tesla&#8217;s <a href="https://www.benzinga.com/news/earnings/24/07/39918390/tesla-q2-earnings-highlights-revenue-beat-eps-miss-robotaxi-update-2024-growth-rate-to-be-notably-l?itm_source=parsely-api">second-quarter earnings call on Tuesday</a>.
What Happened: During <a href="https://www.benzinga.com/news/earnings/24/07/39918390/tesla-q2-earnings-highlights-revenue-beat-eps-miss-robotaxi-update-2024-growth-rate-to-be-notably-l">Tesla&#8217;s second-quarter earnings call</a>, Musk said, &#8220;ARK Invest thinks, on the order of $5 trillion, I think they are probably not wrong. And long-term Optimus, I think, it achieves a valuation several times that number.&#8221;
He further estimated potential <a href="https://www.benzinga.com/news/24/06/39246781/elon-musk-thinks-humanoid-robots-will-one-day-exceed-human-population-from-nvidias-project-gr00t-to">demand for humanoid robots</a> could exceed 20 billion units globally, covering both consumer and industrial applications. &#8220;There are 8 billion people on earth. So it&#8217;s 8 billion right there. Then you&#8217;ve got all of the industrial uses, which is probably at least as much, if not, way more. So I suspect that the long-term demand for general-purpose humanoid robots is in excess of 20 billion units,&#8221; Musk said.
This alignment between ARK&#8217;s analysis and Musk&#8217;s vision highlights Tesla&#8217;s commitment to diversifying beyond electric vehicles into AI and robotics.
As Tesla continues to develop its humanoid robot, Optimus, with plans for <a href="https://www.benzinga.com/news/24/07/39880470/elon-musk-pushes-back-optimus-timeline-says-teslas-humanoid-robot-will-hopefully-be-available-for-ot">limited production starting next year</a>, investors and industry watchers will closely monitor whether this bold vision can translate into reality.
See Also: <a href="https://www.benzinga.com/news/24/07/39883677/investors-anticipate-unraveling-of-trump-trade-as-biden-exits-presidential-race-but-analyst-says-its?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Investors Anticipate Unraveling Of &#8216;Trump Trade&#8217; As Biden Exits Presidential Race, But Analyst Says &#8216;It&#8217;s A Bit Too Early For The Markets To Declare Victory For Trump&#8217;</a>
Why It Matters: Earlier this year, Wood, CEO of ARK Invest, reaffirmed her bullish stance on Tesla despite a <a href="https://www.benzinga.com/markets/equities/24/02/36998382/cathie-wood-backs-tesla-despite-sharp-downturn-says-robotaxis-will-help-change-the-landscape-ent">sharp downturn in its stock</a> price. Wood emphasized the transformative potential of autonomous taxi networks, predicting a turnaround driven by these innovations.
In February, Wood reaffirmed her projection that her favorite electric vehicle company could reach $2,000 within five years, noting plans to revise the target. This valuation would imply a market capitalization exceeding $5 trillion for Tesla.&nbsp;
During the second-quarter&nbsp;results, Tesla reported a revenue of $25.5 billion, surpassing Street consensus estimates. However, the company&#8217;s EPS, operating margins, and free cash flow fell short of expectations, leading to a decline in Tesla&#8217;s stock. 
Musk discussed <a href="https://www.benzinga.com/news/earnings/24/07/39918390/tesla-q2-earnings-highlights-revenue-beat-eps-miss-robotaxi-update-2024-growth-rate-to-be-notably-l">various operational aspects</a>, including a delay in the robotaxi project and the potential postponement of the Mexican Gigafactory due to tariff concerns. 
Gene Munster, a tech analyst at Deepwater Asset Management, highlighted Musk&#8217;s strong conviction regarding vehicle autonomy. Musk stated that those who do not believe in Tesla&#8217;s <a href="https://www.benzinga.com/markets/equities/24/07/39922671/elon-musks-strong-conviction-highlighted-by-gene-munster-anyone-who-doesnt-believe-that-tesla-wi">ability to solve vehicle autonomy</a> should not hold its stock. 
Price Action: Tesla&#8217;s stock closed at $246.38 on Tuesday, down 2.04% for the day. In after-hours trading, the stock fell further 7.77%. Year to date, the stock has declined 0.82%, according to <a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39918390/tesla-q2-earnings-highlights-revenue-beat-eps-miss-robotaxi-update-2024-growth-rate-to-be-notably-l?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Q2 Earnings Highlights: Revenue Beat, EPS Miss, Robotaxi Update, 2024 Growth Rate To Be &#8216;Notably Lower&#8217; Than 2023</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Elon Musk Thinks Cathie Wood-Led Ark Is 'Probably Not Wrong' With Its $5 Trillion Valuation For Tesla, Cites Potential Of Optimus Humanoid Robot

Verastem Oncology, (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTM#NASDAQ">VSTM</a>), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock and accompanying warrants to purchase up to 13,333,334 shares of its common stock at a combined offering price to the public of $3.00 per share and accompanying warrant. In lieu of common stock to certain investors, Verastem Oncology offered pre-funded warrants to purchase up to an aggregate of 5,000,000 shares of its common stock and accompanying warrants to purchase up to 5,000,000 shares of its common stock at a combined offering price to the public of $2.999 per pre-funded warrant and accompanying warrant, which represents the per share public offering price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant. The warrants have an exercise price of $3.50 per share, are exercisable immediately and will expire 18 months from the date of issuance.

VSTM

Reported Earlier, Verastem Oncology Prices $55M Public Offering Of 13,333,334 Common Stock, Warrants And Pre-Funded Warrants

Reported Earlier, RTX's Collins Aerospace To Relocate Singapore Plant To Advanced $250M Seletar Aerospace Park Facility

&nbsp;Freebird Airlines has selected Collins Aerospace, an RTX business (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) to add a comprehensive suite of digital solutions enabling the airline to make proactive decisions to improve operations across its A320 fleet of aircraft.

Freebird Airlines Leverages RTX's Ascentia For Proactive Maintenance And Operational Efficiency

Teck Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TECK#NYSE">TECK</a>) reported quarterly earnings of C$0.79 per share which beat the analyst consensus estimate of C$0.69 by 14.49 percent. This is a 35.25 percent decrease over earnings of C$1.22 per share from the same period last year. The company reported quarterly sales of C$3.873 billion which missed the analyst consensus estimate of C$4.020 billion by 3.65 percent. This is a 10.06 percent increase over sales of C$3.519 billion the same period last year.

Earnings Beats

Earnings Misses

TECK

Teck Resources Q2 2024 Adj EPS C$0.79 Beats C$0.69 Estimate, Sales C$3.873B Miss C$4.020B Estimate

Investment bank Citi upgraded shares of cryptocurrency trading platform, Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), from neutral to buy, anticipating an improved regulatory landscape for cryptocurrency assets.
What Happened: Analysts led by Peter Christiansen raised their guidance on the cryptocurrency-linked stock from neutral at $260 to a buy with a target of $345, according to a Bloomberg <a href="https://www.businesstimes.com.sg/companies-markets/banking-finance/coinbase-wins-citi-upgrade-crypto-regulatory-optimism">report </a>Tuesday.
"Shifts in the U.S. Election landscape and the Supreme Court's overturning of the long-standing Chevron precedent has changed our view on Coinbase's regulatory risks," Christiansen wrote.
The analyst added that the upcoming U.S. elections are taking a positive pivot toward the cryptocurrency industry in the wake of President Joe Biden's withdrawal from the presidential race.&nbsp;
&#8220;President Joe Biden's time in office had led many to conclude that the potential for pro-cryptocurrency legislation would fare better under a different administration."
Furthermore, the analyst believes that the Supreme Court&#8217;s decision to remove the Chevron Defence Doctrine, which limits regulators&#8217; power, could benefit Coinbase in its ongoing legal tussle with the SEC.
See Also:<a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39359780/dogecoin-shiba-inu-floki-are-dino-coins-says-trader-he-likes-these-3-other-meme-coins-as-b?itm_source=parsely-api"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39922826/elon-musk-agrees-with-dogedesigner-funding-for-trump-supporting-super-pac-is-far-below-45m">Elon Musk Agrees with DogeDesigner: Funding For Trump-Supporting Super PAC Is &#8216;Far Below&#8217; $45M A Month So Far</a>
Why It Matters: Coinbase is one of the most high-profile cryptocurrency-associated stocks on Wall Street, with a market capitalization of $63.26 billion.
Shares of the company have jumped nearly 70% year-to-date, coinciding with the broader recovery in the cryptocurrency market. This follows a lackluster performance during the 2022-23 bear market when the stock failed to reach $100.
Coinbase was hit by an enforcement action by the SEC on charges of operating an unregistered securities exchange. In response, the cryptocurrency exchange <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39526310/coinbase-sues-sec-and-fdic-over-alleged-attempts-to-stifle-crypto-industry">has also sued federal regulators</a>, accusing them of hindering the industry&#8217;s growth.
Price Action: Shares of Coinbase closed 2.38% lower at $258.83 during Tuesday's regular trading session, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. 
Photo by rafapress on Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39923307/senator-cynthia-lummis-slams-biden-administrations-dangerous-scheme-to-impose-30-tax-on-bi">Senator Cynthia Lummis Slams Biden Administration&#8217;s &#8216;Dangerous Scheme&#8217; To Impose 30% Tax On Bitcoin Mining, Call It &#8216;Blatant Attack&#8217; On American Excellence</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

COIN

Biden's Exit Spurs Bullish Outlook? Citi Upgrades Coinbase Amid Favorable Crypto Regulatory Shifts

EV giant Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) on Tuesday reiterated its plans to start producing <a href="https://www.benzinga.com/news/24/07/39743027/tesla-unveils-new-model-3-variant-with-longer-range-eligible-for-7-500-tax-credit">new electric vehicles</a> in the first half of 2025, putting an end to concerns about an aging lineup. 
What Happened: The new vehicles, Tesla said, also include more affordable models.
The last mass-market vehicle introduced by Tesla was the Model Y crossover SUV, of which the company started deliveries in early 2020. Though Tesla started delivering its stainless steel Cybertruck last year, it is targeted towards more premium EV buyers. 
New Vehicles But On Old Production Lines: The new vehicles, Tesla said, will be produced on the same manufacturing lines as Tesla&#8217;s current lineup. While the move will result in less cost reduction than expected before, it will allow the company to fully utilize its current capacity before investing in new manufacturing lines. Tesla also cited &#8220;uncertain times&#8221; for the decision it deems will allow it to increase vehicle volume in a more capex-efficient manner.
Tesla teased <a href="https://www.benzinga.com/news/24/06/39331612/elon-musk-teases-three-new-vehicles-at-teslas-annual-shareholder-meeting-more-affordable-model-incom">three upcoming vehicles</a> at its annual shareholder meeting in June. While one is expected to be the company&#8217;s dedicated robotaxi product, the other is assumed to be the next-generation roadster, while the third is expected to be a wholly new vehicle of which little is known. 
Musk Refuses Details: Company CEO Elon Musk on Tuesday refused to share more details on the company&#8217;s new vehicles alleging that it might affect near-term sales. 
&#8220;We&#8217;re going to make great products in the future just like we have in the past, end of story,&#8221; Musk said.
Tesla&#8217;s Q2 Earnings: Tesla stock closed down 2% at $246.38 on Tuesday and fell 7.8% after-hours after the company <a href="https://www.benzinga.com/news/earnings/24/07/39918390/tesla-q2-earnings-highlights-revenue-beat-eps-miss-robotaxi-update-2024-growth-rate-to-be-notably-l">reported adjusted earnings per share </a>of 52 cents, lower than the street consensus estimate of 62 cents. 
Tesla&#8217;s second-quarter revenue rose 2% year-over-year to $25.5 billion, with operating margin dropping to 6.3% from the 9.6% reported for the corresponding period of last year. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39880470/elon-musk-pushes-back-optimus-timeline-says-teslas-humanoid-robot-will-hopefully-be-available-for-ot">Elon Musk Pushes Back Optimus Timeline, Says Tesla&#8217;s Humanoid Robot Will &#8216;Hopefully&#8217; Be Available For Other Companies By 2026</a></li>
</ul>
Photo courtesy: Shutterstock

Tesla Reiterates New Electric Vehicles On Track For 2025, But CEO Elon Musk Refuses To Divulge Details: 'We're Going To Make Great Products'

Alphabet Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) reported <a href="https://www.benzinga.com/news/earnings/24/07/39917921/alphabet-q2-earnings-revenue-beat-eps-beat-innovation-at-every-layer-of-the-ai-stack-and-more">second-quarter earnings results</a> on Tuesday, and while the tech giant met analyst estimates and expectations, it fell short on YouTube advertising revenue.
What Happened: During the earnings call, Michael Nathanson from Moffett questioned the faster growth of Google Search compared to YouTube. In the second quarter, YouTube&#8217;s year-on-year revenue growth experienced a deceleration compared to the first quarter. 
In response, Alphabet&#8217;s CFO, Ruth Porat, expressed satisfaction with YouTube&#8217;s performance. She attributed the slowdown to a challenging comparison with the first quarter of the last year when YouTube was rebounding from a period of negative year-on-year growth. 
See Also:&nbsp;<a href="https://www.benzinga.com/markets/equities/24/07/39871636/crowdstrike-issues-statement-following-massive-outage-that-stemmed-from-content-update-for-windo?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">CrowdStrike Issues Statement Following Massive Outage That Stemmed From Content Update For Windows Hosts: &#8216;This Was Not A Cyberattack&#8217;</a>
&#8220;We&#8217;re really pleased with YouTube, the YouTube team, all that was done. It was driven by the brand followed by direct response. And they have very strong ongoing operating metrics,&#8221; she stated.
Porat also said that YouTube&#8217;s revenue growth in the second quarter faced several headwinds compared to the first quarter. Foreign exchange fluctuations also impacted results, she said.
Alphabet CEO Sundar Pichai also chimed in, discussing the ongoing development of multimodal models and their future relevance to YouTube. 
&#8220;In terms of getting real generative audio, video experience is working well. I think there is still &#8212; it&#8217;s going to take some time. But over time, obviously, it will be deeply relevant to YouTube. And so, it&#8217;s an area I&#8217;m excited about in the future,&#8221; he said.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Despite not meeting estimates, YouTube&#8217;s ad revenue still grew, reaching $8.66 billion, up from $7.66 billion in the same quarter last year. 
Alphabet&#8217;s second-quarter revenue was $84.742 billion, surpassing the consensus estimate of $84.202 billion. The tech giant&#8217;s quarterly earnings of $1.89 per share also beat analyst estimates of $1.85 per share. 
This marks the sixth consecutive quarter that Alphabet has outperformed analyst estimates on both the top and bottom lines, according to data from&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Price Action: As of the latest update, Alphabet&#8217;s Class A shares declined by 2.19% in after-hours trading, settling at $177.80, while the Class C shares fell by 2.18%, reaching $179.59.
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Photo by Sky Motion on Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39877477/microsoft-blames-european-commission-agreement-as-reason-it-cant-secure-windows-like-apple-secures-m?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Microsoft Blames European Commission Agreement As Reason It Can&#8217;t Secure Windows Like Apple Secures MacOS After CrowdStrike Outage</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

As Google Search's Growth Outpaces That Of YouTube, Alphabet CFO Says 'Really Pleased' With Platform: Here's Why

Nidec (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NJDCY#OTC">NJDCY</a>) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.13 by 23.08 percent. This is a 20 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $4.16 billion which beat the analyst consensus estimate of $4.05 billion by 2.69 percent. This is a 0.78 percent increase over sales of $4.13 billion the same period last year.

NJDCY

Nidec Q1 EPS $0.16 Beats $0.13 Estimate, Sales $4.16B Beat $4.05B Estimate

Stora Enso (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SEOAY#OTC">SEOAY</a>) reported quarterly earnings of $0.07 per share. This is a 125.86 percent increase over losses of $(0.29) per share from the same period last year. The company reported $2.48 billion in sales this quarter. This is a 4.25 percent decrease over sales of $2.59 billion the same period last year.

SEOAY

Stora Enso Q2 EPS $0.07 Up From $(0.29) YoY, Sales $2.48B Down From $2.59B YoY

Niclas Rosenlew is currently Group CFO at the Swedish stock-listed industrial company SKF, a position held since 2019. Prior to his current role, he held a CFO position at Basware, and senior finance positions at Microsoft and Nokia. Niclas holds a Master of Science degree in Finance.

Stora Enso Names Niclas Rosenlew As New Group Chief Financial Officer, Effective January 2025

Malaysia and Singapore are intensifying their regulation of social media and online marketplaces to tackle the rise in online scams and protect minors.
What Happened: Malaysia will require platforms like Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) owned Facebook, Elon Musk&#8216;s X, and ByteDance-owned TikTok to obtain licenses by year-end.
The Malaysian Communications and Multimedia Commission (MCMC) stated that platforms must register annually or face penalties of up to 500,000 ringgit ($107,000), <a href="https://asia.nikkei.com/Spotlight/Cybersecurity/Malaysia-and-Singapore-tighten-oversight-of-Facebook-others">reported</a> Nikkei Asia on Tuesday.
Neighboring Singapore has already mandated social media and online marketplaces to detect and act against scams. The Ministry of Home Affairs issued new codes of practice last month, requiring platforms like Mark Zuckerberg-owned Facebook and Carousell to verify sellers&#8217; identities.
Experts, including Adrian Hia from Kaspersky, highlighted the need for these measures due to the anonymity of online platforms, which cybercriminals exploit. He said, &#8220;Phishing, ransomware, and scams remain the most pressing issues in Southeast Asia.&#8221; In 2022, Malaysian police reported losses of 2.5 billion ringgit due to online scams.
Singapore saw a record 46,563 scam cases in 2023, with losses amounting to 651.8 million Singapore dollars ($486 million). The new regulations aim to curb these rising numbers by the end of the year.
&#8220;The primary objective of the regulatory framework is to ensure a safe and secure online ecosystem for all Malaysians, particularly our children,&#8221; the regulator,&nbsp;the Malaysian Communications and Multimedia Commission said, according to the report. 
See Also: <a href="https://www.benzinga.com/markets/equities/24/07/39815808/elon-musk-claps-back-after-gavin-newsom-shares-donald-trumps-drop-to-your-knees-and-beg-post-abo?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Claps Back After Gavin Newsom Shares Donald Trump&#8217;s &#8216;Drop To Your Knees And Beg&#8217; Post About Tesla CEO From 2022: &#8216;You Never Get Off Your Knees&#8217;</a>
Why It Matters: Online scams have become increasingly sophisticated, often leveraging the likenesses of celebrities to deceive users. For instance, Musk <a href="https://www.benzinga.com/markets/cryptocurrency/23/05/32656339/which-celebrities-are-used-most-in-social-media-and-ad-scams-heres-where-musk-and-bezos-ra">has been a frequent target</a>, with scammers using his image to promote fraudulent Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and cryptocurrency schemes. This trend underscores the urgency for stricter regulations.
The use of <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38895127/elon-musk-deepfake-scam-used-to-promote-fraudulent-crypto-trading-platform-hong-kongs-fina">deepfake technology</a> to create convincing but fake videos of celebrities has added another layer of complexity to online scams. The Hong Kong Securities and Futures Commission recently warned about a fraudulent platform using deep fakes of Musk to lure victims.
Moreover, platforms like Facebook have faced criticism for their slow response to scam-related issues. A notable case involved TikTok star Grace Wolstenholme, who suffered financial losses due to a <a href="https://www.benzinga.com/markets/equities/24/05/39033691/facebook-refuses-to-remove-fake-account-costing-tiktok-star-grace-wolstenholme">fake account impersonating</a> her on Facebook. Despite her efforts, it took Meta five months to remove the fraudulent account.
These incidents highlight the growing need for regulatory measures to protect users from increasingly sophisticated online scams. With platforms like <a href="https://www.benzinga.com/general/24/06/39210347/zuckerbergs-quiet-retail-takeover-facebook-marketplace-has-4x-customers-more-than-amazon">Facebook Marketplace</a> having a massive user base, the potential for scams is significant. The new regulations in Malaysia and Singapore aim to address these challenges by enforcing stricter oversight and accountability.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39910831/tesla-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>
Photo courtesy: Unsplash
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

Social Media

Global

$BTC

Elon Musk's X, Mark Zuckerberg-Owned Facebook, And TikTok Face Stricter Regulations As Malaysia And Singapore Tighten Oversight On Social Media To Combat Online Scams

Mind Medicine (MindMed) Inc. (MNMD) Q1 2024 Earnings Call Transcript

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors

MNMD

The world of psychedelics is evolving rapidly, and the <a href="http://www.benzinga.com/events/psychedelics/?UTM_source=article">Benzinga Psychedelics Capital Conference</a> is the premier event for those who want to be part of this exciting journey. Scheduled for <a href="http://www.benzinga.com/events/psychedelics/?UTM_source=article">April 13th</a>, this year&#39;s edition follows the well-established <a href="http://bzcannabis.com">Cannabis Capital Conference</a> (CCC) and will take place at the luxurious <a href="http://www.benzinga.com/events/psychedelics/?UTM_source=article">Fontainebleau Miami Beach Hotel</a> in Florida. The conference boasts an impressive lineup of keynote speakers and specialized leaders in psychedelics advisory, who will be discussing the latest trends and innovations in the field.

Below is a breakdown of some of the things you can expect at the amazing event.

<h3>Psychedelics 101</h3>

The conference will kick off with &quot;Psychedelics 101,&quot; a panel that delves into the history of psychedelics and their importance in treating health conditions that conventional treatments have failed to address. The discussion will explore the ancestral use of psychedelics and the therapy surrounding their treatment, including preparation and integration. Panelists include Simeon Schnapper of JLS, Natalie Ginsberg from MAPS, Najla Guthrie, CEO of Wellbeing Digital Sciences, and Cody Shandraw of Ambria Capital. The panel will be moderated by Bryan Passman, Co-Founder of Hunter + Esquire.

<h3>Dr. Joe Tucker, CEO of Enveric</h3>

The first Fireside chat will feature Dr. Joe Tucker, CEO of Enveric Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>), in conversation with moderator Kaia Roman from Psycheceutical (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BWVI#OTC">BWVI</a>).

<h3>The Business of Consciousness</h3>

The second panel, &quot;The Business of Consciousness,&quot; will examine the growth market of psychedelics, with insights from David Traylor, Sr. Managing Director of Golden Eagle Partners, Andrew Chomer from Integrated.VC, Dan Ahrens of AdvisorShares - which issues the AdvisorShares Psychedelics ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSIL#NYSE">PSIL</a>), and Maria Velkova from Tabula Rasa. Todd Boren will moderate the

<h3>Tracking MDMA Approvals</h3>

The third panel will focus on tracking MDMA approvals, providing updates on MAPS&#39; Phase 3 MDMA trials for PTSD, advanced Phase 2 trials by COMPASS Pathways (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) (psilocybin for treatment-resistant depression), and MindMed (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MMDCF#OTC">MMDCF</a>) (LSD for general anxiety disorder). Panelists will also discuss changes in federal regulations, national surveys on psychedelic use, and the FDA&#39;s current regulations for advancing new mental health treatments. The panel will be moderated by Courtney Barnes and will feature Robert Velarde of Iter Investments, Michael Mullette from MAPS, Nick Kadysh, CEO of PharmAla Biotech, and George McBride, Chief Communications Officer at Clerkenwell Health.

Afternoon Keynote: Matthew Johnson from Johns Hopkins

Matthew Johnson of Johns Hopkins will deliver the afternoon keynote, providing valuable insights into the future of psychedelics research and development.

<h3>From the Ground Up: Infrastructure Built for Healing</h3>

The second Fireside chat will focus on building infrastructure for healing, with panelists Cody Shandraw of Ambria Capital and Tyler Zakovich. The conversation will be moderated by Daniel Carcillo, CEO of Wesana (OTC:<a class="ticker" href="https://www.benzinga.com/stock/WSNAF#OTC">WSNAF</a>).

<h3>Ketamine, Strength in Numbers</h3>

The fourth panel will discuss the off-label use of ketamine for various mental health conditions, different therapeutic approaches, the importance of integration, and the potential for misuse. Panelists include Kathryn Walker from Revitalist, Jeff Becker, CEO of Bexson, Cory Jones from Healing Maps, and Julia Mirer, Director of Strategy &amp; Impact at Nushama. Matt Zorn of Yetter Coleman will moderate the discussion.

<h3>Lessons From Legal Psilocybin Markets</h3>

The fifth panel will explore lessons from legal psilocybin markets in Oregon, Colorado and Quebec. The discussion will cover the organization of license granting for production, delivery, and therapeutic support, as well as the ways legislation is guiding the practical application of psilocybin-assisted therapy. Panelists will also address the differences between legal and illegal practices and the current state of decriminalization, particularly in Colorado. Speakers include Rodman Law&#39;s Nadav Aschner, Joseph from Chacruna, Zappy Zapolin of Psycheceutical, and Justin Kirkland, Chief Science Officer at Optimi Health (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OPTHF#OTC">OPTHF</a>). The panel will be moderated by Farrell Miller of Benzinga.

<h3>NextGen Psychedelics</h3>

The final panel, &quot;NextGen Psychedelics,&quot; will discuss the current state of development of this subset of psychedelics, including the most important clinical trials and innovative substances. Panelists will also delve into the legal pathways for these substances, especially if they are not hallucinogenic, and their targeted indications. Featured speakers are Dr. Joseph Tucker from Enveric, Evan Levine, CEO of PsyBio Therapeutics, Claire Stawnyczy, CEO of Lophos, and James Gillian, Interim CEO of Tryp Therapeutics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TRYPF#OTC">TRYPF</a>). The panel will be moderated by Anne Donohoe from KCSA.

The 2023 <a href="http://www.benzinga.com/events/psychedelics/?UTM_source=article">Benzinga Psychedelics Capital Conference</a> promises to be an enlightening and engaging event for all attendees, whether they are newcomers to the field or seasoned professionals. Don&#39;t miss this opportunity to connect with industry leaders, stay up to date on the latest trends, and gain valuable insights into the rapidly evolving world of psychedelics.

What Happened:&nbsp;According to the&nbsp;Multidisciplinary Association of Psychedelic Studies (MAPS), a&nbsp;non-profit organization,&nbsp;the FDA is close to&nbsp;greenlighting MDMA as a treatment for PTSD. MAPS reported positive results from a phase-3 trial testing the efficacy of MDMA-assisted therapy. Pharamphorum outlined the study in an article <a href="https://pharmaphorum.com/news/fda-backs-late-stage-trial-mdma-post-traumatic-stress/" style="text-decoration-line:none">here.&nbsp;</a>

The study found that the <a href="https://pharmaphorum.com/news/mdma-on-track-for-2023-approval-as-ptsd-therapy-says-developer/" style="text-decoration-line:none">majority (67%) of PTSD patients that participated in three </a>MDMA-assisted therapy sessions had such positive&nbsp;results, that the patients no longer qualified for a PTSD diagnosis.&nbsp;

The study, which included 90 participants, also found that 88% of the patients saw a significant reduction in symptoms, which mirrored MAPS&rsquo; findings from its phase 2 trial.&nbsp;

The FDA originally recognized MDMA as a <a href="https://pharmaphorum.com/news/fda-backs-late-stage-trial-mdma-post-traumatic-stress/" style="text-decoration-line:none">potential approach for PTSD in 2017. </a>Now, with more positive results from studies like the MAPS&rsquo; phase 3 trial, the FDA will be more likely to fully greenlight MDMA as a treatment for PTSD, which will allow biotech companies to conduct further studies and develop drugs that will eventually hit the market. 
Here are three companies that will benefit from the FDA greenlighting MDMA:&nbsp;

<a href="https://www.fieldtriphealth.com/" style="text-decoration-line:none">Field Trip Health LMT</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRP#NASDAQ">FTRP</a>) is a company that is utilizing psychedelic-assisted therapy sessions. Patients can go to Field Trip locations in the U.S., Canada or Europe to undergo ketamine-assisted therapy. 
FDA approval of MDMA would allow Field Trip to expand its current offerings with MDMA-assisted therapy. Currently, Field Trip&rsquo;s stock is trading around $1.30 a share but could see a nice bounce if and when the FDA approves MDMA. 
<a href="https://www.atai.life/programs/" style="text-decoration-line:none">Atai Life Sciences</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAI#NASDAQ">ATAI</a>) is one of the leading biotech companies discovering and developing treatments derived from psychedelic compounds. Atai already has an MDMA-derived drug in its pipeline, EMP-01, in collaboration with Empath Bio.&nbsp;

If the FDA approves MDMA, it will help Atai as it will further interest and investments into the psychedelic biotech space.&nbsp;

<a href="https://mindmed.co/" style="text-decoration-line:none">MindMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MMDCF#OTC">MMDCF</a>) is another biotech company exploring the benefits of psychedelic-assisted therapies and treatments. Like Atai, MindMed is actively exploring the efficacy and safety of different psychedelic compounds such <a href="https://mindmed.co/wp-content/uploads/2022/03/MindMed_CorpDeck_3.10.22.pptx.pdf" style="text-decoration-line:none">as LSD, MDMA and DMT.&nbsp;</a>

The same story with Atai, FDA approval of MDMA will lead to more investments and attention to the psychedelic biotech industry.&nbsp;

Learn more about what&#39;s happening in this exciting sector at Benzinga&#39;s upcoming <a href="https://www.benzinga.com/events/psychedelics/">Psychedelics Capital Conference</a> to be held on&nbsp;April 19 at Miami Beach&#39;s Fontainebleau Hotel. Tickets still available <a href="https://www.benzinga.com/events/psychedelics/">HERE</a>

<div><img alt="april_2022_psychedelics_ad_-_728x90_-_option_c_1_0.png" src="https://www.benzinga.com/files/images/2022/April/06/april_2022_psychedelics_ad_-_728x90_-_option_c_1_0.png" style="height:77px; width:624px" /></div>

Media company Global Trac Solutions, Inc. (OTCP:PSYC) and authorities behind psychedelic news and information platform Psychedelic Spotlight, announced that Psychedelic Spotlight will host its first &ldquo;CEO Roundtable&rdquo; on Feb. 15.

 
The event is scheduled to be streamed live on YouTube via The Psychedelic Investor channel, and will be moderated by James Hallifax, journalist and content director for Psychedelic Spotlight. Three of the most prominent leaders of drug development companies within the burgeoning medicinal psychedelic industry will be featured: Doug Drysdale, CEO of Cybin Corp., (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CYBN#AMEX">CYBN</a>) Robert Barrow, CEO and Board Director of MindMed, (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MMDCF#OTC">MMDCF</a>) and Ronan Levy co-founder and executive chairman of Field Trip Health. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRP#NASDAQ">FTRP</a>)

 
&ldquo;We are thrilled for this incredible opportunity to bring the leaders of MindMed, Cybin and Field Trip together for one event,&rdquo; Hallifax, stated. &ldquo;I&rsquo;m not sure that there&rsquo;s ever been a live digital conference with such a high caliber of business leaders in the psychedelics space. I am excited to hear these executives discuss, amongst themselves, the future of this industry and on which topics they agree and disagree. Everyone watching will get an unparalleled opportunity to learn exactly where the medicinal psychedelic space is going in the near future.&rdquo;

 
PSYC CEO, David Flores, commented: &ldquo;Our core focus in 2022 is to fully maximize our growing presence within the medicinal psychedelic industry through our amazing Psychedelic Spotlight platform in order to solidify our position as a leading informational hub for this space. Not only do I see l this &ldquo;CEO Roundtable&rdquo; as an excellent opportunity for us to further strengthen our authority within the industry by bringing together leaders from three of the most influential psychedelic drug discovery companies on the market, but I believe it will also serve as a blueprint to utilize in the development of future, monetizable events hosted by Psychedelic Spotlight and The Psychedelic Investor.&quot;

&nbsp;

<h3>Benzinga Psychedelics Conference</h3>

&nbsp;

This spring, another psychedelics-themed event will be hosted by Benzinga. The first <a href="https://www.benzinga.com/events/psychedelics/">Benzinga Psychedelics Capital Conference</a>, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022, in Miami, Florida. 
Benzinga is proud to announce Kevin O&rsquo;Leary, Chairman of O&rsquo;Shares Investment Advisers and host of ABC&rsquo;s Shark Tank as a keynote speaker and panelist for the conference. MindMed and Cybin together with other big names in the industry will be part of this event as well.

Photo: Courtesy of <a class="c-link" href="https://unsplash.com/@cadop?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText" rel="noopener noreferrer" tabindex="-1" target="_blank">Mathew Schwartz</a> on <a class="c-link" href="https://unsplash.com/s/photos/magic-mushrooms?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText" rel="noopener noreferrer" tabindex="-1" target="_blank">Unsplash</a>

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Mind Medicine Inc Warrants(07/01/2024)

News

Latest news for Mind Medicine Inc Warrants(07/01/2024) (OTC:MMDCF) Stock

Monday, April 03, 2023

Wednesday, April 06, 2022

Monday, February 14, 2022